Project

Oligonucleotides for Medical Applications

Acronym
OLIGOMED
Code
41U08921
Duration
01 January 2021 → 30 June 2025
Funding
European funding: framework programme, Regional and community funding: Special Research Fund
Research disciplines
  • Natural sciences
    • Other chemical sciences not elsewhere classified
Keywords
oligonucleotides
 
Project description

Modified functional ONs will be synthesized. These include modifications with porphyrins, furan, cholesterol, lipids, m3G-CAP and triphosphates. Green chemistry aspects will be addressed by using chemoenzymatic syntheses, using novel enzymes created by directed protein evolution at ultrahigh throughput in droplets. The functional ONs will be designed to detect genetic disorders with ultra-high sensitivity, to stabilise secondary structures such as GQs and triplexes, cross-link intracellular targets such as miRNAs, for mapping disease relevant genes.

 

 
 
 
Disclaimer
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency (REA). Neither the European Union nor the authority can be held responsible for them.